submit pool data along with Indian patient data: CDSCO panel Tells MSN Laboratories Over Vigabatrin Tablets Dr. Divya Colin30 Aug 2023 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major MSN Laboratories to manufacture and market the antiepileptic drug Vigabatrin, the...
MSN Laboratories Gets CDSCO Panel Nod To Manufacture, Market Selexipag for Injection Dr. Divya Colin20 July 2023 6:00 PM ISTNew Delhi: The drug major MSN Laboratories has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
MSN Lab Gets CDSCO Panel Nod To Manufacture, Market Vigabatrin Powder for Oral Solution Dr. Divya Colin28 Jun 2023 6:00 PM ISTNew Delhi: The drug major MSN Laboratories has got approval from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
MSN Lab Gets CDSCO Panel Nod to Manufacture, Market Nelarabine Injection Dr. Divya Colin24 Jun 2023 6:00 PM ISTNew Delhi: In a significant development, the drug major MSN Laboratories has got the green signal from the Subject Expert Committee (SEC) functional...
MSN Lab gets CDSCO Panel nod for phase III CT of Elagolix Tablets Dr. Divya Colin19 Feb 2023 6:00 PM ISTNew Delhi: The drug major MSN Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
MSN Labs Gets CDSCO Panel Nod To Manufacture, Market Fesoterodine Fumarate ER tablets Dr. Divya Colin4 Jan 2023 6:00 PM ISTNew Delhi: In response to the Phase III clinical trial report of Fesoterodine Fumarate extended release tablets 4 mg and 8 mg, the Subject Expert...
Submit revised protocol for Ticagrelor SR tablets: CDSCO panel tells MSN Labs Susmita Roy15 Feb 2022 5:44 PM ISTNew Delhi: Opining that the Phase III clinical trial protocol presented by the drug maker MSN Laboratories was inadequate with respect to...
MSN Labs gets USFDA nod for generic version of Cangrelor in India Ruchika Sharma17 Dec 2021 1:02 PM ISTHyderabad: Close on the heels of securing Drug Controller General of India's approval for CANREAL injection (generic version of Cangrelor) in India,...
Dr Reddys, MSN Labs launch of generic Empagliflozin may lead to court battle Farhat Nasim20 Oct 2021 2:01 PM ISTHyderabad: Taking head-on collision with Boehringer Ingelheim over blockbuster diabetes drug, two Indian pharma giants have recently launched their...
MSN Labs launches renal cancer treatment Cabolong Ruchika Sharma24 Sept 2021 11:30 AM ISTHyderabad: MSN Labs, a city-based pharma company on Thursday announced the launch of Cabolong, a branded generic of Cabozantinib for treatment of...
MSN Labs, DRDE ink pact for COVID drug 2-DG Ruchika Sharma10 July 2021 11:00 AM ISTNew Delhi: Drug firm MSN Laboratories on Friday said it has entered into a licence agreement with the Defence Research & Development Establishment...
MSN Labs begins COVID drug Molnupiravir phase III trial Ruchika Sharma26 May 2021 12:23 PM ISTMolnupiravir is an experimental drug having antiviral properties and is currently under clinical-stage study for COVID treatment.
